Invega Hafyera

(new medication launch)

One of the first things I worked on at FCB Chicago was the launch of a new medication for people living with schizophrenia that only needs to be taken twice a year. It’s delivered as an injection instead of a daily pill so we needed to make patients aware of the benefits this can offer while assuring them of its efficacy.